Movie Casting Call
Author:
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
May 6, 2026
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
April 7, 2026
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 2, 2026
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
March 31, 2026
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT
March 20, 2026
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
March 16, 2026
Milestone Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 20, 2026
March 12, 2026